查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1935301

語音生物標記市場按治療用途、最終用戶和地區分類

Vocal Biomarkers Market, By Therapeutic Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年，語音生物標記市場價值將達到 37.168 億美元，到 2033 年將達到 101.687 億美元，2026 年至 2033 年的複合年成長率為 15.5%。

報告內容 報告詳情
基準年： 2025 2026年市場規模： 37.168億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
預測期（2026-2033年）複合年成長率： 15.50% 2033 年的預測值： 101.687億美元

語音可以作為一種有效的工具，用於識別憂鬱症、帕金森氏症和冠狀動脈疾病等疾病的存在及其風險。此外，從事語音技術研究的機構和公司正在合作尋找語音生物標記物，以輔助疾病的精準診斷。語音生物標記技術有望成為醫學診斷領域的開創性創新，使檢測慢性疾病的微創診斷程序成為可能。例如，Beyond Verbal, Inc.、Cogito Corporation 和 Sonde Health 等公司正在開發基於語音的平台，用於診斷身心健康狀況。

市場動態

語音生物標記技術有望徹底改變我們診斷身心健康的方式，並革新整個醫療保健產業。這項以語音為基礎的技術能夠實現早期診斷和預防性治療，幫助醫院、診所和個人監測自身健康狀況並採取適當的醫療措施。

主要企業正致力於透過合作來鞏固市場地位並強化產品系列，這有望推動市場成長。例如，2016年6月，Sonde Health Inc.從麻省理工學院林肯實驗室獲得了一項技術許可，用於開發一種基於語音的技術平台，該平台旨在監測和診斷各種身心疾病。此外，2016年，Beyond Verbal, Inc.與梅奧診所合作，研究並識別可用於診斷身心健康的語音生物標記。

本次調查的主要特點

  • 本報告對全球語音生物標記市場進行了詳細分析，並以 2025 年為基準年，給出了預測期（2026-2033 年）的市場規模和復合年成長率（%）。
  • 該報告還重點介紹了各個細分市場的潛在商機，並概述了該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本報告根據以下參數介紹了全球語音生物標記市場主要企業的概況：公司概況、財務表現、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
  • 本報告的研究結果將幫助負責人和經營團隊就即將推出的產品、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球語音生物標記市場報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過語音生物標記市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、監管與趨勢分析

  • 市場動態
    • 促進要素
    • 抑制因素
    • PEST分析
    • 波特五力分析
    • 市場機遇
    • 法規環境
    • 重大進展
    • 產業趨勢

4. 2026-2033年全球語音生物標記市場（依治療應用分類）

  • 精神疾病
  • 呼吸系統疾病
  • 心血管疾病

5. 2026-2033年全球語音生物標記市場（依最終用戶分類）

  • 醫院
  • 健康保險公司
  • 學術和研究機構
  • 政府機構

6. 2026-2033年全球語音生物標記市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第7章 競爭情勢

  • 熱圖分析
  • 市佔率分析（3x3矩陣）
  • 公司簡介
    • Beyond Verbal, Inc.
    • Sonde Health Inc.
    • Sharecare, Inc.
    • IBM Corporation
    • Cogito Corporation
    • AudEERING
    • VoiceSense
    • Winterlight Labs
    • Ellipsis Health
    • Vocalis Health

第8章 分析師建議

  • 機器
  • 分析師觀點
  • Coherent Opportunity Map

第9章各節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI101

Vocal Biomarkers Market is estimated to be valued at USD 3,716.8 Mn in 2026 and is expected to reach USD 10,168.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 15.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3,716.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 15.50% 2033 Value Projection: USD 10,168.7 Mn

Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson's disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.

Market Dynamics

The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.

Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter's voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.

Key features of the study

  • This report provides in-depth analysis of the global vocal biomarkers market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global vocal biomarkers market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Corporation, and Cogito Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
  • The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market

Market Segmentation

  • Therapeutic Application Insights (Revenue, USD Mn, 2026 - 2033)
    • Psychological Disorders
    • Respiratory Disorders
    • Cardiovascular Disorders
  • End User Insights (Revenue, USD Mn, 2026 - 2033)
    • Hospitals
    • Health Insurers
    • Academic & Research Institutions
    • Government Organizations
  • Regional Insights (Revenue, USD Mn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Beyond Verbal, Inc.
    • Sonde Health Inc.
    • Sharecare, Inc.
    • IBM Corporation
    • Cogito Corporation
    • AudEERING
    • VoiceSense
    • Winterlight Labs
    • Ellipsis Health
    • Vocalis Health

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Vocal Biomarkers Market, By Therapeutic Application, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Psychological Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Respiratory Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cardiovascular Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Vocal Biomarkers Market, By End User, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Health Insurers
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Academic & Research Institutions
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Government Organizations
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Vocal Biomarkers Market, By Region, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country/Region, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Beyond Verbal, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sonde Health Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sharecare, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • IBM Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Cogito Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • AudEERING
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • VoiceSense
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Winterlight Labs
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Ellipsis Health
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Vocalis Health
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates

8. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact